EUVIMEDEUVIMED entdecken
Crossref

Late-Onset Parkinson’s Disease with Atypical Tremor and Early Cognitive Dysfunction: Implications for Levodopa Pharmacokinetics and Emerging Drug Delivery Systems

Dr V P Eswaran, Dr Shankar S, Dr C Arul Murugan

International Journal of Drug Delivery Technology · 25.04.2026 · 16 (22s)

DOI: 10.25258/ijddt.16.22s.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Dr V P Eswaran und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by degeneration of dopaminergic neurons in the substantia nigra pars compacta, resulting in dopamine deficiency in the basal ganglia. Classical motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability. However, substantial clinical heterogeneity exists, particularly in late-onset cases (>70 years), which may feature atypical tremor morphology and early cognitive impairment. Levodopa remains the cornerstone therapy but is limited by variable gastrointestinal absorption due to delayed gastric emptying, dietary amino-acid competition, and gut microbial metabolism. Case Presentation: We report a 79-year-old man with late-onset parkinsonism presenting with asymmetrical highfrequency large-amplitude resting tremor, bradykinesia, shuffling gait, and executive cognitive dysfunction within 1 year of motor onset. Secondary causes were excluded by normal MRI and laboratory investigations. Diagnosis of idiopathic PD with atypical features was confirmed after excluding progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and corticobasal degeneration (CBD). Levodopa–carbidopa (Syndopa) was initiated with structured dosing, 2- hour meal–drug separation, and tablet dissolution in lemon juice to enhance gastric dissolution and absorption.

Conclusion

Moderate improvement in tremor and gait was achieved with pharmacokinetic optimization, though the response remained suboptimal compared with classical PD. This case highlights phenotypic variability in late-onset PD and the value of simple bedside strategies. Emerging intranasal and nanoparticle-based drug delivery systems offer promise for stable dopaminergic stimulation in atypical presentations. Novelty: This case is unique in demonstrating the coexistence of atypical high-frequency large-amplitude tremor and early executive cognitive dysfunction in confirmed late-onset idiopathic Parkinson’s disease, along with real-time clinical improvement using simple pharmacokinetic optimization strategies (acidic dissolution with lemon juice and strict meal– drug separation), which are rarely emphasized together in routine clinical reporting.

Zitieren

APA

Eswaran, D. V. P., S, D. S., & Murugan, D. C. A. (2026). Late-Onset Parkinson’s Disease with Atypical Tremor and Early Cognitive Dysfunction: Implications for Levodopa Pharmacokinetics and Emerging Drug Delivery Systems. International Journal of Drug Delivery Technology, 16(22s). https://doi.org/10.25258/ijddt.16.22s.3

Vancouver

Eswaran DVP, S DS, Murugan DCA. Late-Onset Parkinson’s Disease with Atypical Tremor and Early Cognitive Dysfunction: Implications for Levodopa Pharmacokinetics and Emerging Drug Delivery Systems. International Journal of Drug Delivery Technology. 2026;16(22s). doi:10.25258/ijddt.16.22s.3

BibTeX
@article{Eswaran2026,
  author = {Eswaran, Dr V P and S, Dr Shankar and Murugan, Dr C Arul},
  title = {Late-Onset Parkinson’s Disease with Atypical Tremor and Early Cognitive Dysfunction: Implications for Levodopa Pharmacokinetics and Emerging Drug Delivery Systems},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {22s},
  doi = {10.25258/ijddt.16.22s.3}
}
Kostenlos starten →